VA to make new nasal spray drug available for treatment-resistant depression


shadow

Today the U.S. Department of Veterans Affairs (VA) announced its health care providers will now be able to offer the newly approved Spravato nasal spray for treatment-resistant depression.

The treatment will be made available to Veterans based on their individual medical needs combined with providers’ clinical assessments.

The move follows the March 5 Food and Drug Administration (FDA) approval of Spravato (esketamine) nasal spray. Spravato was approved for use in conjunction with an oral antidepressant for the treatment of treatment-resistant depression in adults.

“We’re pleased to be able to expand options for Veterans with depression who have not responded to other treatments,” said VA Secretary Robert Wilkie. “It reflects our commitment to seek new ways to provide the best health care available for our nation’s Veterans.”

Spravato will be available through a restricted distribution system under an FDA-approved Risk Evaluation and Mitigation Strategy (REMS). The purpose of the REMS is to mitigate the risks of serious adverse outcomes and the potential abuse and misuse of Spravato.

VA health care providers will monitor Veterans for serious adverse outcomes, such as sedation and difficulty with attention, judgment and thinking (dissociation), abuse and misuse, worsening of depression and suicidal thoughts and behaviors.

Veterans will self-administer Spravato nasal spray under the direct observation of a health care provider in a certified medical facility, and then must be monitored by a health care provider for at least two hours after receiving their dose. Spravato cannot be dispensed directly to Veterans for use at home.

For additional information on access to Mental Health Support for Veterans, visit VA Mental Health. Veterans in immediate crisis may call the Veterans Crisis Line at 800-273-8255 and press 1, text to 838255 or chat online at Veterans Crisis Line.

Author

Media Relations

The Office of Media Relations serves as the interface with news media representatives from newspapers and electronic media for the Department. OMR arranges interviews, provides press releases and answers media queries.

Comments

  1. William L Hopkins    

    So peacetime volunteers don’t get a “thank you for your service” ? And, you tell a war veteran with PTSD he deserves no more attention than you?

  2. Pamela S Lee    

    What ARE the ‘eligibility’ requirements? They’ve been treating me for depression for +33 years now. Do I qualify?

  3. Kevin Gikk    

    As a Viet Nam Vet who has been antidepressant resistant for over six years. How do I become eligible for the new Spravato medication?

  4. Tommy V Parker    

    My mental health provider was told by Fayetteville Veterans Administration pharmacy that Spravato inhaler has not been approved for treatment. Can you provide any helpful information about procurement. Veteran: Tommy V Parker e-mail: (redacted)

  5. Barry Bell    

    So the patient has to go to the VA every time he needs a dose? Ridiculous.

  6. Madelyn Sandall    

    When will the VA recognize non wartime veterans as equal to those during wartime. Not the veteran who VOLUNTEERED to serve that there was no war?

Comments are closed.